dna 23andme - Search News

Order byBest matchMost fresh

Regeneron Pharmaceuticals to buy 23andMe and its data

Digest more

Now we know who's getting 23andMe's DNA data. Meet Regeneron Pharmaceuticals.

Regeneron Pharmaceuticals announced that it would acquire most of 23andMe's assets for $256 million.

· 19h · on MSN

23andMe sold in bankruptcy: What it means for your DNA data

· 4h · on MSN

Pharmaceutical company Regeneron buying 23andMe for $256 million

Regeneron agrees to buy bankrupt 23andMe

Regeneron Pharmaceuticals said on Monday it will buy genetic testing firm 23andMe Holding for $256 million through a bankruptcy auction, and promised to prioritize the ethical use of customers' DNA da...

· 22h

· 1d

Struggling DNA testing firm 23andMe to be bought for $256m

· 23h

23andMe (and Your Genetic Data) Sold to Regeneron in Bankruptcy Auction

23andMe sells its most valuable asset to biotech company Regeneron, which promises to keep your DNA private

Regeneron said Monday it will “prioritize the privacy, security and ethical use” of the personal DNA data from about 15 million people in a $256 million deal to acquire assets of bankrupt 23andMe Hold...

· 1d

Biotechnology company Regeneron buying 23andMe for $256 million

· 1d

Bankrupt DNA testing company 23andMe to be bought by Regeneron

22hon MSN

Bankrupt DNA Company 23andMe Expected to Be Purchased for $256M: What Users Need to Know About Their Privacy

Genetics company 23andMe is expected to be purchased by Regeneron Pharmaceuticals, according to announcements shared by both companies Both companies vowed that Regeneron is committed to comply with 23andMe's privacy policies,

Lohud.com, Westchester County on MSN22h

Regeneron to acquire 23andMe DNA testing firm. How that could impact your genetic data

Regeneron announced a plan to acquire genetic testing firm 23andMe through bankruptcy court, including access to personal genetic data. What to know

Daily Voice on MSN4h

Westchester-Based Regeneron Buying Bankrupt 23andMe For $256M, Pledges To Protect DNA Data

Regeneron Pharmaceuticals will acquire embattled DNA testing company 23andMe in a $256 million court-supervised sale, promising to honor existing privacy protections and continue consumer services with no changes.

23andMe was once worth $6 billion. What's left of the DNA testing startup is being bought for $256 million.

Regeneron is buying the assets of 23andMe, which filed for Chapter 11 bankruptcy in March after facing a series of hurdles including a data breach.

Timeline: 23andMe’s Journey From DNA Testing Pioneer to Bankruptcy Sale

What happened to 23andMe? Here's a look at its history from launch to bankruptcy and acquisition by Regeneron.

18hon MSN

Genetic data will be safeguarded with 23andMe sale, drugmaker vows

The pharmaceutical giant plans to continue offering 23andMe’s DNA testing service and pledged to adopt its privacy practices to protect customer data.

1don MSN

Your 23andMe data is getting a new owner. Here's how to delete your account.

Your 23andMe data is getting a new owner — so what are your options moving forward? The DNA testing company announced on Monday that its assets are being acquired by Regeneron Pharmaceuticals. The sale renewed concerns from some customers online about their data and how its new owner plans to use it.